Troponin I

Drug Profile

Troponin I

Alternative Names: Cartilage-derived inhibitor; CDI

Latest Information Update: 09 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Childrens Hospital Boston
  • Class Contractile proteins; Eye disorder therapies; Microfilament proteins; Muscle proteins; Troponin
  • Mechanism of Action Angiogenesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer metastases; Eye disorders; Macular degeneration; Solid tumours

Most Recent Events

  • 09 Aug 2007 Discontinued - Preclinical for Cancer metastases in USA (unspecified route)
  • 09 Aug 2007 Discontinued - Preclinical for Eye disorders in USA (Ophthalmic)
  • 09 Aug 2007 Discontinued - Preclinical for Macular degeneration in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top